239 related articles for article (PubMed ID: 18787536)
1. Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance.
Holme SA; Whatley SD; Roberts AG; Anstey AV; Elder GH; Ead RD; Stewart MF; Farr PM; Lewis HM; Davies N; White MI; Ackroyd RS; Badminton MN
J Invest Dermatol; 2009 Mar; 129(3):599-605. PubMed ID: 18787536
[TBL] [Abstract][Full Text] [Related]
2. A homoallelic FECH mutation in a patient with both erythropoietic protoporphyria and palmar keratoderma.
Minder EI; Schneider-Yin X; Mamet R; Horev L; Neuenschwander S; Baumer A; Austerlitz F; Puy H; Schoenfeld N
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1349-53. PubMed ID: 20337824
[TBL] [Abstract][Full Text] [Related]
3. [Inheritance in erythropoietic protoporphyria].
Schmitt C; Ducamp S; Gouya L; Deybach JC; Puy H
Pathol Biol (Paris); 2010 Oct; 58(5):372-80. PubMed ID: 20850938
[TBL] [Abstract][Full Text] [Related]
4. Exclusion of ferrochelatase gene mutations in patients with seasonal palmoplantar keratoderma.
Schimmel RJ; Van Tuyll Van Serooskerke AM; Bladergroen RS; Van Steensel AM; van Geel M; Pasmans SG; Frank J
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):111-7. PubMed ID: 19656459
[TBL] [Abstract][Full Text] [Related]
5. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
Bloomer JR; Wang Y; Singhal A; Risheg H
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
[TBL] [Abstract][Full Text] [Related]
6. A homozygous mutation in the ferrochelatase gene underlies erythropoietic protoporphyria associated with palmar keratoderma.
Méndez M; Poblete-Gutiérrez P; Morán-Jiménez MJ; Rodriguez ME; Garrido-Astray MC; Fontanellas A; Frank J; de Salamanca RE
Br J Dermatol; 2009 Jun; 160(6):1330-4. PubMed ID: 19298273
[No Abstract] [Full Text] [Related]
7. The molecular genetics of erythropoietic protoporphyria.
Elder GH; Gouya L; Whatley SD; Puy H; Badminton MN; Deybach JC
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):118-26. PubMed ID: 19656460
[TBL] [Abstract][Full Text] [Related]
8. Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
Balwani M; Naik H; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Overbey JR; Wang B; Singal AK; Liu LU; Desnick RJ
JAMA Dermatol; 2017 Aug; 153(8):789-796. PubMed ID: 28614581
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of erythropoietic protoporphyria in the U.K.
Whatley SD; Mason NG; Holme SA; Anstey AV; Elder GH; Badminton MN
Br J Dermatol; 2010 Mar; 162(3):642-6. PubMed ID: 20105171
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.
Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M
Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030
[TBL] [Abstract][Full Text] [Related]
11. Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members.
Berroeta L; Man I; Goudie DR; Whatley SD; Elder GH; Ibbotson SH
Br J Dermatol; 2007 Nov; 157(5):1030-1. PubMed ID: 17711525
[TBL] [Abstract][Full Text] [Related]
12. Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation.
Gouya L; Puy H; Lamoril J; Da Silva V; Grandchamp B; Nordmann Y; Deybach JC
Blood; 1999 Mar; 93(6):2105-10. PubMed ID: 10068685
[TBL] [Abstract][Full Text] [Related]
13. Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease.
Herrero C; To-Figueras J; Badenas C; Méndez M; Serrano P; Enríquez-Salamanca R; Lecha M
Arch Dermatol; 2007 Sep; 143(9):1125-9. PubMed ID: 17875872
[TBL] [Abstract][Full Text] [Related]
14. A homozygous mutation in the ferrochelatase gene underlies erythropoietic protoporphyria associated with palmar keratoderma--reply.
Holme SA; Anstey AV; Whatley SD; Elder GH; Badminton MN
Br J Dermatol; 2009 Oct; 161(4):966-7. PubMed ID: 19673873
[No Abstract] [Full Text] [Related]
15. Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria.
Whatley SD; Mason NG; Holme SA; Anstey AV; Elder GH; Badminton MN
J Invest Dermatol; 2007 Dec; 127(12):2790-4. PubMed ID: 17597821
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietic protoporphyria.
Lecha M; Puy H; Deybach JC
Orphanet J Rare Dis; 2009 Sep; 4():19. PubMed ID: 19744342
[TBL] [Abstract][Full Text] [Related]
17. Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria.
Kong XF; Ye J; Gao DY; Gong QM; Zhang DH; Lu ZM; Lu YM; Zhang XX
J Hepatol; 2008 Feb; 48(2):375-9. PubMed ID: 18160121
[TBL] [Abstract][Full Text] [Related]
18. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
[TBL] [Abstract][Full Text] [Related]
19. Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
Br J Dermatol; 2016 Jan; 174(1):172-5. PubMed ID: 26280465
[TBL] [Abstract][Full Text] [Related]
20. Functional associations of genetic variants involved in the clinical manifestation of erythropoietic protoporphyria in the Argentinean population.
Colombo FP; Rossetti MV; Méndez M; Martínez JE; Enríquez de Salamanca R; del C Batlle AM; Parera VE
J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):754-62. PubMed ID: 22591014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
